483
Intas Pharmaceuticals LimitedIntas Pharmaceuticals Limited – FDA 483, Feb 28, 2020
Record Details
An FDA inspection of Intas Pharmaceuticals Limited in Ahmedabad, India, revealed significant deficiencies in their quality control unit. The firm failed to ensure process validation for packaging was completed and approved before distributing drug batches to the US market. Additionally, the Quality Assurance unit did not conduct required manufacturing investigations following confirmed out-of-specification results for impurities in stability testing.
View Company Profile
ID · 4840cbe4-0699-45d1-b557-35037fad9e93
Other documents for Intas Pharmaceuticals Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.